Biotech startups in Philadelphia, Pennsylvania
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Latus Bio | Philadelphia | Series A | $43.0M | 2026-05-04 |
| Proscia | Philadelphia | Series D | $50.0M | 2025-03-19 |
| Aro Biotherapeutics | Philadelphia | Series B | $41.5M | 2023-11-28 |
| GEMMABio | Philadelphia | Seed | $34.0M | 2024-12-23 |
| Halo Labs | Philadelphia | Series C | $7.0M | 2022-07-08 |
| BioLattice | Philadelphia | Seed | $575K | 2026-03-30 |
| Pera Labs | Philadelphia | Seed | $150K | 2023-06-05 |
7 rows of the CSV in 5 of its 18 columns.
- The 52 biotech startups in Philadelphia, Pennsylvania have raised $1.7B in total.
- 7 of them closed their most recent round in the last 12 months, $308.3M combined.
- The largest of those rounds is Alveus Therapeutics' $197.0M Series A, dated January 2026.
- The most recent is Peptaris' $250K seed round on 22 September 2026.
- Ben Franklin Technology Partners is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 46 companies (88%).
- 22% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (54% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
7 of 52| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Latus Bio | Latus Bio develops gene therapies for central nervous system disorders using screened AAV capsids. | Biotech | Series A | $43.0M | 2026-05-04 | $97.0M | Gaingels, 8VC, Ben Franklin Technology Partners +1 | 11 to 50 | 2022 |
| BioLattice | BioLattice develops tissue healing solutions. | Biotech | Seed | $575K | 2026-03-30 | $585K | SOSV, SOSV SF & NY (Fka IndieBio), Startup302 | 1 to 10 | 2017 |
| Proscia | Proscia develops digital pathology software that helps laboratories manage and analyze pathology data. | Artificial intelligence | Series D | $50.0M | 2025-03-19 | $129.8M | Flybridge, Scale Venture Partners, Fusion Fund +2 | 101 to 250 | 2014 |
| GEMMABio | GEMMABio develops gene therapies for people living with rare diseases. | Biotech | Seed | $34.0M | 2024-12-23 | $34.0M | Earlybird Venture Capital, Double Point Ventures, Bioluminescence Ventures | 51 to 100 | 2024 |
| Aro Biotherapeutics | Aro Biotherapeutics develops tissue-targeted genetic medicines using its proprietary Centyrin technology. | Biotech | Series B | $41.5M | 2023-11-28 | $166.5M | Johnson & Johnson Innovation, Northpond Ventures, Biotechnology Value Fund +1 | 11 to 50 | 2017 |
| Pera Labs | Pera Labs develops digiceuticals and AI-powered solutions for fertility. | Artificial intelligence | Seed | $150K | 2023-06-05 | $1.4M | Jumpstart Foundry, Malta Enterprise, Phase One Ventures | 11 to 50 | 2019 |
| Halo Labs | Halo Labs is a biotechnology company focused on analytical instrumentation and biopharma. | Biotech | Series C | $7.0M | 2022-07-08 | $26.8M | National Science Foundation, Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners +1 | 11 to 50 | 2011 |
Table 1. Biotech startups in Philadelphia, Pennsylvania: the 7 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 52.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Latus Bio | Latus Bio develops gene therapies for central nervous system disorders using screened AAV capsids. | Biotech | Series A | $43.0M | 2026-05-04 | $97.0M | Gaingels, 8VC, Ben Franklin Technology Partners +1 | 11 to 50 | 2022 |
| 2 | BioLattice | BioLattice develops tissue healing solutions. | Biotech | Seed | $575K | 2026-03-30 | $585K | SOSV, SOSV SF & NY (Fka IndieBio), Startup302 | 1 to 10 | 2017 |
Table 2. Biotech startups in Philadelphia, Pennsylvania: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Ben Franklin Technology Partners | Angel group | University Park, United States | 2 | 4% | 1 | Latus Bio |
| 2 | Modi Ventures | Fund of funds | Houston, United States | 1 | 2% | 1 | Latus Bio |
| 3 | 8VC | Venture capital firm | Austin, United States | 1 | 2% | 1 | Latus Bio |
| 4 | Gaingels | Syndicate | Burlington, United States | 1 | 2% | 1 | Latus Bio |
| 5 | Fusion Fund | Venture capital firm | Palo Alto, United States | 1 | 2% | ||
| 6 | Scale Venture Partners | Venture capital firm | Foster City, United States | 1 | 2% | ||
| 7 | Hitachi Ventures | Corporate venture arm | Munich, Germany | 1 | 2% | ||
| 8 | Alpha Intelligence Capital | Venture capital firm | Luxembourg | 1 | 2% | ||
| 9 | Flybridge | Venture capital firm | New York, United States | 1 | 2% | ||
| 10 | Johnson & Johnson Innovation | Corporate venture arm | Cambridge, United States | 1 | 2% | ||
| 11 | BioMotiv | Startup accelerator | Cleveland, United States | 1 | 2% | ||
| 12 | Biotechnology Value Fund | Venture capital firm | San Francisco, United States | 1 | 2% | ||
| 13 | Northpond Ventures | Private equity firm | Bethesda, United States | 1 | 2% | ||
| 14 | Double Point Ventures | Venture capital firm | Palm Beach, United States | 1 | 2% | ||
| 15 | Bioluminescence Ventures | Venture capital firm | San Francisco, United States | 1 | 2% |
Table 3. Biotech startups in Philadelphia, Pennsylvania: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 46 | 88% | $1.5B |
| Software | 8 | 15% | $150.5M |
| Artificial intelligence | 4 | 8% | $135.5M |
Table 4. Biotech startups in Philadelphia, Pennsylvania by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 4 | 8% | $50K |
| Seed | 25 | 48% | $1000K |
| Series A | 11 | 21% | $25.0M |
| Series B | 7 | 13% | $41.5M |
| Series C | 2 | 4% | $30.0M |
| Series D+ | 3 | 6% | $50.0M |
Table 5. Biotech startups in Philadelphia, Pennsylvania by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 14% | |
| September 2026 | 1 | 14% | $250K |
| July 2026 | 1 | 14% | $67.4M |
| May 2026 | 1 | 14% | $43.0M |
| March 2026 | 2 | 29% | $635K |
| January 2026 | 1 | 14% | $197.0M |
Table 6. Biotech startups in Philadelphia, Pennsylvania: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 13% | $308.3M |
| 2025 | 5 | 10% | $287.6M |
| 2024 | 3 | 6% | $34.0M |
| 2023 | 5 | 10% | $47.5M |
| 2022 | 4 | 8% | $102.0M |
| 2021 | 4 | 8% | $35.0M |
Table 7. Biotech startups in Philadelphia, Pennsylvania by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 14% |
| 2020 to 2022 | 4 | 8% |
| 2015 to 2019 | 20 | 40% |
| 2010 to 2014 | 9 | 18% |
| Before 2010 | 10 | 20% |
Table 8. Biotech startups in Philadelphia, Pennsylvania by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 27 | 54% |
| 11 to 50 | 16 | 32% |
| 51 to 100 | 6 | 12% |
| 101 to 250 | 1 | 2% |
Table 9. Biotech startups in Philadelphia, Pennsylvania by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Philadelphia, Pennsylvania. On 16 November 2026 that is 52 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 7 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 52 rows: 14 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Philadelphia, Pennsylvania are on the list?
- 52, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 52 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.